PODDInsulet Corporation

1. Sep 21, 2026On September 21, 2026, Insulet Corporation (the “Company”) entered into the Ninth Amendment to Credit Agreement (the “Amendment”) with the lenders and other parties thereto and Morgan Stanley Senior Funding, Inc., as administrative agent (the “Agent”), amending that certain Credit Agreement, dated as of May 4, 2021 …Material agreement entered · Form 8-K
2. Sep 16, 2026Adoption of Nonqualified Deferred Compensation Plan On September 14, 2026, the Talent and Compensation Committee (the "Committee") of the Board of Directors (the "Board") of Insulet Corporation (the "Company") approved and adopted the Insulet Nonqualified Deferred Compensation Plan (the "Plan"), with such Plan to be …Director or officer change · Form 8-K
3. Sep 10, 2026On September 3, 2026, Timothy J. Scannell, a member of the Board of Directors (the "Board") of Insulet Corporation (the "Company"), notified the Company of his decision to step down from the Board for health reasons, effective September 3, 2026.Director or officer change · Form 8-K
4. Aug 5, 2026Insulet Reports Second Quarter 2026 Results.Earnings release · press release
5. Jun 25, 2026On June 24, 2026, the Board of Directors (the "Board") of Insulet Corporation (the "Company") appointed Jonathan J. Mazelsky as a Class II director, effective July 1, 2026.Director or officer change · Form 8-K
6. May 26, 2026Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets.Regulation FD disclosure · press release
7. May 21, 2026On May 20, 2026, the Board of Directors of Insulet Corporation (the “Company”) approved the amendment and restatement of the Company’s Bylaws (the “Amended Bylaws”), effective immediately, to designate the Court of Chancery of the State of Delaware (or if the Court of Chancery of the State of Delaware lacks subject …Charter/bylaw amendment or fiscal-year change · Form 8-K
8. May 6, 2026Insulet Reports First Quarter 2026 Results.Earnings release · press release
9. Mar 12, 2026Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S.Regulation FD disclosure · press release
10. Mar 4, 2026On February 27, 2026, Insulet Corporation (the “Company”) entered into a severance agreement and release (the “Severance Agreement”) with Ana M. Chadwick, the Company’s former Chief Financial Officer.Director or officer change · Form 8-K
11. Feb 24, 2026On December 15, 2025, the Audit Committee of the Board of Directors of the Company notified GT, the Company’s then independent registered public accounting firm, that the Audit Committee selected PwC as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026.Auditor change · Form 8-K/A

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.